[author: Sherri Oslick]
About Court Report: Each week we will report briefly on recently filed biotech and pharma cases.
Biogen Idec MA Inc. v. Kappos
1:12-cv-01171; filed October 19, 2012 in the Eastern District of Virginia
Review and correction of the patent term adjustment calculation made by the U.S. Patent and Trademark Office for U.S. Patent No. 8,163,875 ("Polymer Conjugated Glycosylated Neublastin," issued April 24, 2012). View the complaint here.
